Opto Circuits Ltd Reports Audited Consolidated and Standalone Earnings Results for the Fourth Quarter and Year Ended March 31, 2018
April 30, 2018 at 05:20 am
Share
Opto Circuits (India) Ltd. reported audited consolidated and standalone earnings results for the fourth quarter and year ended March 31, 2018. For the quarter, on standalone basis, the company reported income from operations of INR 245.993 million against INR 96.342 million a year ago. Total income was INR 247.654 million against INR 97.805 million a year ago. Profit before exceptional items and tax was INR 60.942 million against INR 14.218 million a year ago. Profit before tax was INR 60.942 million against loss before tax of INR 215.044 million a year ago. Profit after tax for the period from continuing operations was INR 60.942 million against loss after tax for the period from continuing operations of INR 215.044 million a year ago. Basic and diluted EPS was INR 0.24 against LPS of INR 0.89 a year ago.
For the year, on standalone basis, the company reported income from operations of INR 634.646 million against INR 503.801 million a year ago. Total income was INR 637.103 million against INR 505.500 million a year ago. Profit before exceptional items and tax was INR 100.051 million against loss before exceptional items and tax of INR 14.757 million a year ago. Profit before tax was INR 100.051 million against loss before tax of INR 3,640.414 million a year ago. Profit after tax for the period from continuing operations was INR 100.051 million against loss after tax for the period from continuing operations of INR 3,640.414 million a year ago. Basic and diluted EPS was INR 0.39 against LPS of INR 15.02 a year ago.
For the quarter, on consolidated basis, the company reported income from operations of INR 664.259 million against INR 511.039 million a year ago. Total income was INR 669.737 million against INR 512.743 million a year ago. Profit before exceptional items and tax was INR 108.494 million against loss before exceptional items and tax of INR 60.265 million a year ago. Profit before tax was INR 108.494 million against loss before tax of INR 3,829.019 million a year ago. Profit after tax for the period from continuing operations was INR 107.543 million against loss after tax for the period from continuing operations of INR 3,830.284 million a year ago. Basic and diluted EPS was INR 0.41 against LPS of INR 15.87 a year ago. Profit attributable to the shareholders of the company was INR 106.518 million against loss attributable to the shareholders of the company of INR 3,846.465 million a year ago.
For the year, on consolidated basis, the company reported income from operations of INR 2,283.629 million against INR 2,152.919 million a year ago. Total income was INR 2,295.705 million against INR 2,159.870 million a year ago. Profit before exceptional items and tax was INR 348.855 million against loss before exceptional items and tax of INR 88.218 million a year ago. Profit before tax was INR 364.884 million against loss before tax of INR 5,074.948 million a year ago. Profit after tax for the period from continuing operations was INR 355.899 million against loss after tax for the period from continuing operations of INR 5,083.048 million a year ago. Basic and diluted EPS was INR 1.34 against LPS of INR 21.05 a year ago. Profit attributable to the shareholders of the company was INR 346.217 million against loss attributable to the shareholders of the company of INR 5,100.724 million a year ago.
Opto Circuits (India) Limited is an India-based global medical devices and technology company. The Company and its subsidiaries are engaged in the design, development, manufacture, marketing and distribution of a range of medical products that are used by primary, secondary and tertiary healthcare establishments, as well as in public access facilities, such as fire stations and policy offices in over 150 countries. It specializes in vital signs monitoring, emergency cardiac care, vascular treatments and sensing technologies. Its interventional products include stents, balloons and arteriovenous shunts used for the treatment of coronary and peripheral arterial diseases, as well as catheters and implants. Its products include automated patient monitoring devices and services, vital signs monitors, pulse oximeters, and peripheral artery disease diagnostic equipment. It also sells a range of related products and consumables and offers a portfolio of related training and support services.